MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

Eric Rytkin,1 Karin Mirzaev,1 Irina Bure,1 Kristina Akmalova,1 Sherzod Abdullaev,1 Anastasiia Kachanova,1 Valery Smirnov,2,3 Elena Grishina,1 Natalia Lyakhova,4 Elena Aleshkovich,4 Anna Saribekian,2 Denis Andreev,2 Alexey Shabunin,4 Dmitry Sychev1 1Institute for Molecular and Personalized Medicine,...

Full description

Bibliographic Details
Main Authors: Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
biomarker
mirna
polymorphism
acute coronary syndrome
pharmacogenomics
Online Access:https://www.dovepress.com/micrornas-as-novel-biomarkers-for-p2y12--inhibitors-resistance-predict-peer-reviewed-fulltext-article-PGPM

Internet

https://www.dovepress.com/micrornas-as-novel-biomarkers-for-p2y12--inhibitors-resistance-predict-peer-reviewed-fulltext-article-PGPM

Similar Items